137 related articles for article (PubMed ID: 8166777)
1. Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group.
Chahine RA; Feldman RL; Giles TD; Nicod P; Raizner AE; Weiss RJ; Vanov SK
J Am Coll Cardiol; 1993 May; 21(6):1365-70. PubMed ID: 8166777
[TBL] [Abstract][Full Text] [Related]
2. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
[TBL] [Abstract][Full Text] [Related]
3. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
4. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine and the total ischemic burden: circadian anti-ischemia program in Europe (CAPE) trial-methodology, safety and toleration. The Steering Committee members and all of the investigators.
Detry JM
Cardiology; 1994; 85 Suppl 2():24-30. PubMed ID: 7736484
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
[TBL] [Abstract][Full Text] [Related]
7. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of amlodipine in myocardial ischemia.
Taylor SH
Am Heart J; 1989 Nov; 118(5 Pt 2):1123-6. PubMed ID: 2573266
[TBL] [Abstract][Full Text] [Related]
9. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris.
Taylor SH; Lee P; Jackson N; Cocco G
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S46-9. PubMed ID: 16296709
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).
Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E
J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276
[TBL] [Abstract][Full Text] [Related]
12. A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
Cocco G; Alfiero R
Eur Heart J; 1991 Feb; 12(2):169-74. PubMed ID: 1828420
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of amlodipine for angina pectoris.
Taylor SH
Am J Cardiol; 1994 Jan; 73(3):28A-33A. PubMed ID: 8310973
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
Ezekowitz MD; Hossack K; Mehta JL; Thadani U; Weidler DJ; Kostuk W; Awan N; Grossman W; Bommer W
Am Heart J; 1995 Mar; 129(3):527-35. PubMed ID: 7872184
[TBL] [Abstract][Full Text] [Related]
15. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
Kinnard DR; Harris M; Hossack KF
J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
Pepine CJ; Cooper-DeHoff RM; Weiss RJ; Koren M; Bittar N; Thadani U; Minkwitz MC; Michelson EL; Hutchinson HG;
Am J Cardiol; 2003 Feb; 91(3):274-9. PubMed ID: 12565082
[TBL] [Abstract][Full Text] [Related]
17. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.
Hall R; Chong C
Cardiology; 2001; 96(2):72-7. PubMed ID: 11740135
[TBL] [Abstract][Full Text] [Related]
19. Safety of placebo-controlled trials in vasospastic angina.
Savonitto S; Ardissino D
J Am Coll Cardiol; 1994 Mar; 23(3):831-2. PubMed ID: 8113575
[No Abstract] [Full Text] [Related]
20. A review of amlodipine in myocardial ischaemia.
Taylor SH
Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
